Taro Pharmaceutical Industries Ltd
NYSE:TARO
Taro Pharmaceutical Industries Ltd
Cash from Financing Activities
Taro Pharmaceutical Industries Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Cash from Financing Activities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
T
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Cash from Financing Activities
-$1.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
I
|
InterCure Ltd
TASE:INCR
|
Cash from Financing Activities
₪42.4m
|
CAGR 3-Years
57%
|
CAGR 5-Years
82%
|
CAGR 10-Years
26%
|
Mediwound Ltd
NASDAQ:MDWD
|
Cash from Financing Activities
$22.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
241%
|
CAGR 10-Years
2%
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Cash from Financing Activities
-₪10.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
C
|
Cannassure Therapeutics Ltd
TASE:CSURE
|
Cash from Financing Activities
₪6.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|